These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 3999451

  • 21. Thorium dioxide effects in man. Epidemiological, clinical, and pathological studies (experience in Portugal).
    Da Silva Horta J, Da Motta C, Tavares MH.
    Environ Res; 1974 Oct; 8(2):131-59. PubMed ID: 4455502
    [No Abstract] [Full Text] [Related]

  • 22. Thorium induced hepatic hemangioendothelioma. Roentgen-angiographic findings in two additional cases with clinical "inform and consent" problems.
    Curry JL, Johnson WG, Feinberg DH, Updegrove JH.
    Am J Roentgenol Radium Ther Nucl Med; 1975 Nov; 125(3):671-7. PubMed ID: 1202981
    [Abstract] [Full Text] [Related]

  • 23. [Case of liver cancer caused by thorotrast].
    Abo M, Sugisawa T, Shindo K, Soezima Y, Ichimura H.
    Gan No Rinsho; 1969 Sep; 15(9):822-6. PubMed ID: 5391409
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. History of the use and toxicity of thorotrast.
    Abbatt JD.
    Environ Res; 1979 Feb; 18(1):6-12. PubMed ID: 387405
    [No Abstract] [Full Text] [Related]

  • 28. Thorotrast-associated mucoepidermoid carcinoma of the liver.
    Lambrianides AL, Askew AR, Lefevre I.
    Br J Radiol; 1986 Aug; 59(704):791-2. PubMed ID: 3730778
    [No Abstract] [Full Text] [Related]

  • 29. [Liver cirrhosis and cholangiocarcinoma following Thorotrast administration].
    Vanhaecke J, Hendrickx H, Fevery J, Baert A, Vandenbroucke J, de Wolf-Peeters C, Desmet V, de Groote J.
    Ned Tijdschr Geneeskd; 1979 Dec 29; 123(52):2218-23. PubMed ID: 232542
    [No Abstract] [Full Text] [Related]

  • 30. [Important problems with thorotrast: a liver sarcoma with intraperitoneal hemorrhage].
    Wenz W, Ott G.
    Strahlentherapie; 1965 Jul 29; 127(3):463-9. PubMed ID: 5841464
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pathomorphological characteristics of thorotrast-related cholangiocarcinoma.
    Ito Y.
    Kurume Med J; 1988 Jul 29; 35(2):63-9. PubMed ID: 2848148
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Retaining rate of thorotrast in patients with primary liver cancer: a retrospective survey on thorotrast carcinogenesis].
    Kitabatake T, Morita K, Koga S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1966 Jan 29; 25(10):1166-70. PubMed ID: 5222579
    [No Abstract] [Full Text] [Related]

  • 35. [Malignant hemangioendothelioma of the liver 39 years following one-time thorotrast administration].
    Hardt M, Geisthövel W.
    Med Klin (Munich); 1988 Feb 26; 83(4):151-3. PubMed ID: 3367877
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Thorotrast associated hepatic angiosarcoma with 36 years latency.
    Underwood JC, Huck P.
    Cancer; 1978 Dec 26; 42(6):2610-2. PubMed ID: 569544
    [Abstract] [Full Text] [Related]

  • 38. The legacy of Thorotrast.
    Robertson A.
    Med J Aust; 1983 Nov 26; 2(11):532. PubMed ID: 6633372
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Statistical analysis of Japanese thorotrast-administered autopsy cases.
    Mori T, Kato Y, Shimamine T, Watanabe S.
    Environ Res; 1979 Feb 26; 18(1):231-44. PubMed ID: 227670
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.